Clinical trial
Exploration of the Peripheral Immune System in Subjects With New Onset T1 Diabetes (NOT1D)
NCT02801942 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploration of the Peripheral Immune System in Subjects With New Onset T1 Diabetes (NOT1D)
- Lead sponsor
- GlaxoSmithKline
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 25, 2016
- Completion date
- December 21, 2017
- Enrollment
- 22 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.